Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 1
2007 1
2009 3
2010 2
2011 3
2014 7
2015 8
2016 4
2017 4
2018 3
2019 4
2020 5
2021 4
2022 6
2023 4
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.
Moulis G, Rueter M, Duvivier A, Mahévas M, Viallard JF, Comont T, Chèze S, Audia S, Ebbo M, Terriou L, Lega JC, Jeandel PY, Hemim I, Bozzi S, Daak A, Okada H, Bonnotte B, Michel M, Lapeyre-Mestre M, Godeau B; CARMEN‐France Investigators Group. Moulis G, et al. Among authors: jeandel py. Br J Haematol. 2024 Apr;204(4):1476-1482. doi: 10.1111/bjh.19288. Epub 2024 Jan 24. Br J Haematol. 2024. PMID: 38267268
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
Ollier N, Piel-Julian ML, Mahévas M, Viallard JF, Comont T, Chèze S, Audia S, Ebbo M, Terriou L, Lega JC, Jeandel PY, Bonnotte B, Michel M, Lapeyre-Mestre M, Godeau B, Moulis G. Ollier N, et al. Among authors: jeandel py. Blood. 2023 Sep 21;142(12):1099-1101. doi: 10.1182/blood.2023020311. Blood. 2023. PMID: 37478400 Free article. No abstract available.
Immune thrombocytopenic purpura after COVID-19 infection.
Levraut M, Ottavi M, Lechtman S, Mondain V, Jeandel PY. Levraut M, et al. Among authors: jeandel py. Int J Lab Hematol. 2021 Feb;43(1):e28-e30. doi: 10.1111/ijlh.13346. Epub 2020 Sep 20. Int J Lab Hematol. 2021. PMID: 32951347 Free PMC article. No abstract available.
Obesity: an additional piece in the mosaic of autoimmunity.
Versini M, Aljadeff G, Jeandel PY, Shoenfeld Y. Versini M, et al. Among authors: jeandel py. Isr Med Assoc J. 2014 Oct;16(10):619-21. Isr Med Assoc J. 2014. PMID: 25438447 Free article. Review. No abstract available.
Obesity in autoimmune diseases: not a passive bystander.
Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Versini M, et al. Among authors: jeandel py. Autoimmun Rev. 2014 Sep;13(9):981-1000. doi: 10.1016/j.autrev.2014.07.001. Epub 2014 Aug 2. Autoimmun Rev. 2014. PMID: 25092612 Review.
Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G, Nguyen Y, Amarger S, Aubineau M, Bibes B, Blanchard-Delaunay C, Boccon-Gibod I, Bouillet L, Coppo P, Dalmas MC, Debord-Peguet S, Defendi F, Demoreuil C, Du-Thanh A, Gayet S, Hadjadj J, Jeandel PY, Launay D, Ly KH, Avoy CM, Niault M, Ollivier Y, Pelletier F, Porneuf M, Roos-Weil D, Fain O, Gobert D. Kalmi G, et al. Among authors: jeandel py. J Allergy Clin Immunol Pract. 2024 Jan;12(1):212-222. doi: 10.1016/j.jaip.2023.10.017. Epub 2023 Oct 14. J Allergy Clin Immunol Pract. 2024. PMID: 37844846
Midostaurin in Advanced Systemic Mastocytosis.
Chandesris MO, Damaj G, Canioni D, Brouzes C, Lhermitte L, Hanssens K, Frenzel L, Cherquaoui Z, Durieu I, Durupt S, Gyan E, Beyne-Rauzy O, Launay D, Faure C, Hamidou M, Besnard S, Diouf M, Schiffmann A, Niault M, Jeandel PY, Ranta D, Gressin R, Chantepie S, Barete S, Dubreuil P, Bourget P, Lortholary O, Hermine O; CEREMAST Study Group. Chandesris MO, et al. Among authors: jeandel py. N Engl J Med. 2016 Jun 30;374(26):2605-7. doi: 10.1056/NEJMc1515403. N Engl J Med. 2016. PMID: 27355555 Clinical Trial. No abstract available.
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.
Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL. Belizna C, et al. Among authors: jeandel py. Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Autoimmun Rev. 2018. PMID: 30316994 Review.
59 results